Evidence map›Paper›PMID 41403419›Full record

ArticleERJ open research2025

Patient perspectives and priorities in pleural infection: results of the MIST-3 feasibility trial qualitative substudy.

Eihab O Bedawi, Rebecca Burney, Sophie Harrad, Shakeeb H Moosavi, Jack Seymour, Alison M Condliffe, Emma Hedley, Catherine Henshall, Najib M Rahman

Abstract read
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eihab O BedawiDepartment of Infection, Immunity and Cardiovascular Disease, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.ORCID https://orcid.org/0000-0001-9196-3934
Rebecca BurneyDepartment of Infection, Immunity and Cardiovascular Disease, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.ORCID https://orcid.org/0009-0001-4984-6029
Sophie HarradDepartment of Biological and Medical Sciences, Oxford Brookes University, Oxford, UK.
Shakeeb H MoosaviDepartment of Biological and Medical Sciences, Oxford Brookes University, Oxford, UK.
Jack SeymourOxford Respiratory Trials Unit, University of Oxford, Churchill Hospital, Headington, UK.
Alison M CondliffeDepartment of Infection, Immunity and Cardiovascular Disease, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
Emma HedleyOxford Respiratory Trials Unit, University of Oxford, Churchill Hospital, Headington, UK.
Catherine HenshallOxford Health NHS Foundation Trust, Oxford, UK.
Najib M RahmanOxford Respiratory Trials Unit, University of Oxford, Churchill Hospital, Headington, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The question addressed by the study: The optimal treatment for pleural infection is yet to be determined and recruitment to trials can be challenging. Research into patient priorities in pleural infection is lacking. This qualitative study aimed to help us understand the patient perspective regarding priorities of care, to identify patient-centred study outcomes, and to explore the understanding of the risks and benefits of randomisation to different pleural interventions. Methods: A prospective, multicentre, qualitative study using a semi-structured interview methodology explored key themes addressing the experiences of participation in a pleural infection randomised controlled trial (RCT) of combination intrapleural enzyme therapy Results: Thematic analysis identified five main themes: emotions, level of explanation and understanding, reaction to randomisation, influences on physical wellbeing, and overall experience. Pain was a significant feature due to both the infection and interventions. The overriding emotions described by patients were fear and anxiety. Participants demonstrated high levels of support for randomised allocation to intervention. The answer to the question: A pleural infection patient-reported outcome measure should be developed to assess pain, fatigue, anxiety and breathlessness, so that valid health-related quality of life data can be captured. Pain is an undertreated symptom of pleural infection and should be incorporated into treatment protocols. There was no clear patient preference between the interventions, and a surgical

Identifiers

PMID41403419
PMCPMC12704157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.